BAY86-9766

DRUG2 trials

Sponsors

Bayer

Conditions

Drug InteractionsNeoplasms

Phase 1

Japanese BAY86-9766 Monotherapy Phase I Study

CompletedNCT01179295

Start: 2010-11-19End: 2012-04-27Updated: 2017-06-20

Effect of Ketoconazole on the Pharmacokinetics of Refametinib

CompletedNCT01925638

BayerDrug Interactions

Start: 2013-09-30End: 2013-12-31Updated: 2014-01-08